Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Treatment of multiple sclerosis with interferons]

J Nogales-Gaete1, C Arriagada

  • 1Servicio de Neurologia Hospital Barros Luco Trudean, Facultad de Medicina, Universidad de Chile, Santiago de Chile.

Revista Medica De Chile
|May 1, 1996
PubMed
Summary

Beta interferon shows dose-dependent efficacy for relapsing-remitting multiple sclerosis (MS), reducing exacerbations and disease burden. However, its use requires caution due to cost and duration, with no clear benefit for chronic-progressive MS.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[LACTRIMS consensus document for the pharmacological treatment of the multiple sclerosis and its clinical variants].

Revista de neurologia·2012
Same author

Prognostic factors for amputation in severe burn patients.

Burns : journal of the International Society for Burn Injuries·2012
Same author

Cloning and spatiotemporal expression of RIC-8 in Xenopus embryogenesis.

Gene expression patterns : GEP·2011
Same author

Isolation of viable porcine islets by selective osmotic shock without enzymatic digestion.

Transplantation proceedings·2010
Same author

Interactions of Trametes versicolor, Coriolopsis rigida and the arbuscular mycorrhizal fungus Glomus deserticola on the copper tolerance of Eucalyptus globulus.

Chemosphere·2009
Same author

Contribution of the saprobic fungi Trametes versicolor and Trichoderma harzianum and the arbuscular mycorrhizal fungi Glomus deserticola and G. claroideum to arsenic tolerance of Eucalyptus globulus.

Bioresource technology·2009

Area of Science:

  • Neuroimmunology
  • Clinical Neurology

Context:

  • Multiple sclerosis (MS) pathogenesis remains largely unknown, though often considered autoimmune with potential viral triggers in genetically susceptible individuals.
  • Current MS treatments focus on immune modulation, with interferons being a key therapeutic class.

Purpose:

  • To evaluate the efficacy of beta interferon as a treatment for multiple sclerosis (MS).

Summary:

  • Beta interferon demonstrated dose-dependent efficacy in Phase III clinical trials for the remitting-relapsing form of MS.
  • Treatment with beta interferon led to reduced exacerbation rates and decreased disease burden, as evidenced by Magnetic Resonance Imaging (MRI).
  • Clinical application of beta interferon necessitates caution due to cost and extended treatment duration, primarily recommended for confirmed remitting-relapsing MS.

Impact:

  • Beta interferon is a valuable therapeutic option for specific MS subtypes, guiding clinical practice and patient selection.
  • The findings underscore the importance of targeted immunomodulatory therapies in managing MS.
  • Further research may elucidate the precise mechanisms of action and long-term outcomes of beta interferon therapy in MS.

Related Experiment Videos